Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Rangering i aksjer #17186
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Aksjekurs
$2.17
Markedsverdi
$249.58M
Endring (1 dag)
-1.67%
Endring (1 år)
96.34%
Land
CA
Handel Cardiol Therapeutics Inc. (CRDL)

Kategori

Historikk for aksjesplitt for Cardiol Therapeutics Inc. (CRDL)
Aksjen Cardiol Therapeutics Inc. (symbol: CRDL) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Sep 02, 2026.
Én CRDL-aksje kjøpt før Sep 02, 2026 tilsvarer i dag 0 CRDL-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter